1131 related articles for article (PubMed ID: 11115404)
41. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.
Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F
J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259
[TBL] [Abstract][Full Text] [Related]
42. IL-10 attenuates IFN-alpha-activated STAT1 in the liver: involvement of SOCS2 and SOCS3.
Shen X; Hong F; Nguyen VA; Gao B
FEBS Lett; 2000 Sep; 480(2-3):132-6. PubMed ID: 11034314
[TBL] [Abstract][Full Text] [Related]
43. Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway.
Flores-Morales A; Fernández L; Rico-Bautista E; Umana A; Negrín C; Zhang JG; Norstedt G
Mol Endocrinol; 2001 Sep; 15(9):1471-83. PubMed ID: 11518796
[TBL] [Abstract][Full Text] [Related]
44. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
Auernhammer CJ; Chesnokova V; Bousquet C; Melmed S
Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
[TBL] [Abstract][Full Text] [Related]
45. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
[TBL] [Abstract][Full Text] [Related]
46. 1Alpha,25-dihydroxyvitamin D3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signaling via the Janus kinase (JAK2)/signal transducers and activators of transcription (STAT5) system in osteoblast-like cells.
Morales O; Faulds MH; Lindgren UJ; Haldosén LA
J Biol Chem; 2002 Sep; 277(38):34879-84. PubMed ID: 12107179
[TBL] [Abstract][Full Text] [Related]
47. Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone.
von Laue S; Finidori J; Maamra M; Shen XY; Justice S; Dobson PR; Ross RJ
J Endocrinol; 2000 May; 165(2):301-11. PubMed ID: 10810294
[TBL] [Abstract][Full Text] [Related]
48. STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver.
Davey HW; McLachlan MJ; Wilkins RJ; Hilton DJ; Adams TE
Mol Cell Endocrinol; 1999 Dec; 158(1-2):111-6. PubMed ID: 10630411
[TBL] [Abstract][Full Text] [Related]
49. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
[TBL] [Abstract][Full Text] [Related]
50. Growth hormone down-regulation of Interleukin-1beta and Interleukin-6 induced acute phase protein gene expression is associated with increased gene expression of suppressor of cytokine signal-3.
Wu X; Herndon DN; Wolf SE
Shock; 2003 Apr; 19(4):314-20. PubMed ID: 12688541
[TBL] [Abstract][Full Text] [Related]
51. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo.
Mao Y; Ling PR; Fitzgibbons TP; McCowen KC; Frick GP; Bistrian BR; Smith RJ
Endocrinology; 1999 Dec; 140(12):5505-15. PubMed ID: 10579313
[TBL] [Abstract][Full Text] [Related]
52. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
Tanuma N; Shima H; Nakamura K; Kikuchi K
Blood; 2001 Nov; 98(10):3030-4. PubMed ID: 11698287
[TBL] [Abstract][Full Text] [Related]
53. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
Chen T; Wang LH; Farrar WL
Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
[TBL] [Abstract][Full Text] [Related]
54. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro.
Ling C; Billig H
Endocrinology; 2001 Nov; 142(11):4880-90. PubMed ID: 11606456
[TBL] [Abstract][Full Text] [Related]
55. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
Shen X; Tian Z; Holtzman MJ; Gao B
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation.
Cassatella MA; Gasperini S; Bovolenta C; Calzetti F; Vollebregt M; Scapini P; Marchi M; Suzuki R; Suzuki A; Yoshimura A
Blood; 1999 Oct; 94(8):2880-9. PubMed ID: 10515892
[TBL] [Abstract][Full Text] [Related]
57. Stat1-independent induction of SOCS-3 by interferon-gamma is mediated by sustained activation of Stat3 in mouse embryonic fibroblasts.
Ramana CV; Kumar A; Enelow R
Biochem Biophys Res Commun; 2005 Feb; 327(3):727-33. PubMed ID: 15649407
[TBL] [Abstract][Full Text] [Related]
58. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.
Ding Y; Chen D; Tarcsafalvi A; Su R; Qin L; Bromberg JS
J Immunol; 2003 Feb; 170(3):1383-91. PubMed ID: 12538698
[TBL] [Abstract][Full Text] [Related]
59. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway.
Cooney RN
Shock; 2002 Feb; 17(2):83-90. PubMed ID: 11837794
[TBL] [Abstract][Full Text] [Related]
60. A new protein containing an SH2 domain that inhibits JAK kinases.
Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
